Mahamaya Lifesciences Ltd

544611BSE · IN

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+30
Nu Heights Agency Private Limited
Mahamaya Lifesciences Ltd · BSE
−1,71,600 sh · ₹3.14 Cr
Filed 22 Sept 2026BSE bulk dealview source
ACQUIREDT+30
Nu Heights Agency Private Limited
Mahamaya Lifesciences Ltd · BSE
+19,200 sh · ₹34.59 L
Filed 22 Sept 2026BSE bulk dealview source
REDUCEDT+30
Abundantia Capital VCC - Abundantia Capital III
Mahamaya Lifesciences Ltd · BSE
−1,32,000 sh · ₹2.41 Cr
Filed 22 Sept 2026BSE bulk dealview source
ACQUIREDT+30
Sanjay Popatlal Jain
Mahamaya Lifesciences Ltd · BSE
+3,22,800 sh · ₹5.87 Cr
Filed 22 Sept 2026BSE bulk dealview source
ACQUIREDT+30
Bhatia Suresh
Mahamaya Lifesciences Ltd · BSE
+3,30,000 sh · ₹5.99 Cr
Filed 22 Sept 2026BSE bulk dealview source
ACQUIREDT+30
Sanjay Popatlal Jain
Mahamaya Lifesciences Ltd · BSE
+1,56,000 sh · ₹2.81 Cr
Filed 21 Sept 2026BSE bulk dealview source
REDUCEDStale
Qapla Investments
Mahamaya Lifesciences Ltd · BSE
−1,18,800 sh · ₹2.26 Cr
Filed 19 Aug 2026BSE bulk dealview source
ACQUIREDStale
Nikhil K S
Mahamaya Lifesciences Ltd · BSE
+2,62,800 sh · ₹5.00 Cr
Filed 19 Aug 2026BSE bulk dealview source
ACQUIREDStale
Kifs Enterprise
Mahamaya Lifesciences Ltd · BSE
+2,50,800 sh · ₹4.77 Cr
Filed 19 Aug 2026BSE bulk dealview source

Announcements

The announcements library is part of Pro.

Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.

11 announcements on record for this company.

Part of Pro — upgrade to open